BamSEC and AlphaSense Join Forces
Learn More

Oncotelic Therapeutics Inc

OTC: OTLC    
Share price (12/20/24): $0.03    
Market cap (12/20/24): $12.3 million

Indentures Filter

EX-4.1
from 8-K 5 pages Convertible Promissory Note
12/34/56
EX-4.1
from 8-K 6 pages Mateon Therapeutics, Inc. Convertible Promissory Note
12/34/56
EX-4.2
from 8-K 13 pages Signing Debenture
12/34/56
EX-4.1
from 8-K 14 pages Signing Debenture
12/34/56
EX-4.12
from S-1 14 pages Mateon Therapeutics, Inc. Common Stock Warrant [ ], 2018
12/34/56
EX-4.2
from 8-K 13 pages Mateon Therapeutics, Inc. Common Stock Purchase B Warrant [●], 2018
12/34/56
EX-4.1
from 8-K 13 pages Mateon Therapeutics, Inc. Common Stock Purchase a Warrant [●]
12/34/56
EX-4.12
from S-1/A 17 pages Common Stock Purchase Warrant Mateon Therapeutics, Inc
12/34/56
EX-4.11
from S-1/A 18 pages Placement Agent Common Stock Purchase Warrant Mateon Therapeutics, Inc
12/34/56
EX-4.10
from S-1/A 17 pages Pre-Funded Common Stock Purchase Warrant Mateon Therapeutics, Inc
12/34/56
EX-4.1
from 10-Q 2 pages Mateon Therapeutics, Inc
12/34/56
EX-4.8
from S-3 42 pages Oxigene, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.7
from S-3 41 pages Oxigene, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.2
from 8-K 3 pages Amendment No. 9 to Stockholder Rights Agreement
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant Oxigene, Inc
12/34/56
EX-4.2
from 8-K 3 pages Amendment No. 8 to Stockholder Rights Agreement
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant Oxigene, Inc
12/34/56
EX-4.2
from 8-K 17 pages [Form of Placement Agent Warrant] Common Stock Purchase Warrant Oxigene, Inc
12/34/56
EX-4.1
from 8-K 17 pages [Form of Warrant] Common Stock Purchase Warrant Oxigene, Inc
12/34/56
EX-4.9
from S-1/A 16 pages [Form of Warrant] Common Stock Purchase Warrant Oxigene, Inc
12/34/56